Machine Learning

As Wall Street giants embrace prediction markets, a summit in NYC signals a new era of forecasting. But a fierce regulatory battle looms over their future.

Upwind's new AI Agentic Pack introduces autonomous agents to hunt threats, promising to reshape cloud security by focusing on real-time risks.

Tech leader and space explorer Anousheh Ansari joins Rockefeller's board, a bold move signaling the wealth firm's strategic leap into the age of AI.

Global luxury leaders meet in Milan to tackle margin pressures, a new world map for growth, and the disruptive power of artificial intelligence.

Astrotech cuts R&D to chase sales amid rising losses and falling revenue. Can its advanced detection tech convert a pipeline into profit?

Sony unleashes the FE 100-400mm F4.5 GM OSS, a pricey super-telephoto with a constant aperture and blazing AF aimed at pro sports and wildlife shooters.

ICON plc opens a state-of-the-art San Antonio research unit, aiming to accelerate drug development and improve the patient trial experience.

As aerial threats to the energy grid grow, a new partnership aims to deploy advanced drone detection to protect vital assets from espionage and attack.

A new platform launches to connect accessible tech startups with users and investors, aiming to unify a fragmented but powerful innovation ecosystem.

Benchling launches Model Hub, an integrated platform to democratize AI in biotech, aiming to slash R&D timelines by embedding models into daily workflows.

A new benchmark shows top AI voice tools fail in non-English languages, challenging billion-dollar deployments and exposing deep-rooted linguistic bias.

Czech MedTech firm Stimvia builds a scientific and commercial 'dream team' to launch its non-invasive URIS® therapy for overactive bladder worldwide.

Private equity firm Thurston Group launches Sensorium Clinical Research, a new network aiming to unify top trial sites and streamline medical innovation.

A new price feed for real-world assets like gold and Tesla promises continuous trading, challenging the 9-to-5 financial world and wooing institutions.

A biotech firm says it has grown functional human sperm in a lab and created embryos, a huge leap that could change millions of lives and spark ethical debate.

A $25M payment from partner Chiesi catapults Protalix to a profitable quarter, funding a promising new gout therapy and a broader rare disease strategy.

The new CROSSx Disclosed platform combines Wall Street-style trading relationships with blazing speed, aiming to lower costs and risks for institutions.

A new alliance aims to develop first-in-class drugs for Alzheimer's and Parkinson's by targeting chronic brain inflammation, a key driver of disease.

A new study reveals Efsubaglutide Alfa not only controls diabetes but may also improve the body's own insulin-producing cells, heralding a new era.

A new US-Taiwan partnership will equip unmanned boats with advanced AI, creating autonomous swarms to bolster the island's asymmetric defense strategy.